...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Off to the races again....

based on comparable biotechs for a company going into a phase 3 for a potential blockbuster drug rvx is very undervalued IMO if we awere on the NAsdaq RVX would have much more market exposure and properly valued and a much higher mulitple to what it is now

Share
New Message
Please login to post a reply